Driving vascular endothelial cell fate of human multipotent Isl1+ heart progenitors with VEGF modified mRNA.
Driving vascular endothelial cell fate of human multipotent Isl1+ heart progenitors with VEGF modified mRNA.
复制标题
作者：
不同的多能心脏祖细胞家族在哺乳动物心脏发生过程中不同心脏、平滑肌和内皮细胞谱系的生成中发挥着核心作用。识别驱动这些多能祖细胞的细胞命运决定的精确旁分泌信号，以及开发在体内传递这些信号的新方法，是释放其再生治疗潜力的关键步骤。在此，我们鉴定了位于早期人胎儿心脏流出道（OFT-EC）中的一个人心脏内皮中间体家族，其特征是 Isl1 和 CD144/vWF 的共表达。通过比较人 OFT-EC 和非心脏 EC 表达的血管分泌因子，血管内皮生长因子 (VEGF)-A 被确定为表达最丰富的因子，克隆测定记录了其以 VEGF 受体依赖性方式驱动人胚胎干细胞 (ESC) 衍生的 Isl1+ 祖细胞内皮特化的能力。人 Isl1-EC（从 hESC 衍生的 ISL1+ 祖细胞分化而来的内皮细胞）在心脏内皮祖细胞和心内膜细胞特异性基因的表达方面类似于 OFT-EC，从而证实了其器官特异性。为了确定 VEGF-A 是否可以作为人 ESC 衍生的 Isl1-EC 的体内细胞命运开关，我们建立了一种新方法，使用化学修饰的 mRNA 作为平台，在心血管祖细胞中短暂而高效地表达旁分泌因子。 VEGF-A 的过度表达不仅促进内皮细胞的规范化，还促进人 Isl1+ 祖细胞在体内的植入、增殖和存活（减少细胞凋亡）。从人类多能干细胞中大规模衍生心脏特异性人类 Isl1-EC，加上驱动内皮规范、移植和移植后存活的能力，提出了一种心脏血管再生的新策略。
Distinct families of multipotent heart progenitors play a central role in the generation of diverse cardiac, smooth muscle and endothelial cell lineages during mammalian cardiogenesis. The identification of precise paracrine signals that drive the cell-fate decision of these multipotent progenitors, and the development of novel approaches to deliver these signals in vivo, are critical steps towards unlocking their regenerative therapeutic potential. Herein, we have identified a family of human cardiac endothelial intermediates located in outflow tract of the early human fetal hearts (OFT-ECs), characterized by coexpression of Isl1 and CD144/vWF. By comparing angiocrine factors expressed by the human OFT-ECs and non-cardiac ECs, vascular endothelial growth factor (VEGF)-A was identified as the most abundantly expressed factor, and clonal assays documented its ability to drive endothelial specification of human embryonic stem cell (ESC)-derived Isl1+ progenitors in a VEGF receptor-dependent manner. Human Isl1-ECs (endothelial cells differentiated from hESC-derived ISL1+ progenitors) resemble OFT-ECs in terms of expression of the cardiac endothelial progenitor- and endocardial cell-specific genes, confirming their organ specificity. To determine whether VEGF-A might serve as an in vivo cell-fate switch for human ESC-derived Isl1-ECs, we established a novel approach using chemically modified mRNA as a platform for transient, yet highly efficient expression of paracrine factors in cardiovascular progenitors. Overexpression of VEGF-A promotes not only the endothelial specification but also engraftment, proliferation and survival (reduced apoptosis) of the human Isl1+ progenitors in vivo. The large-scale derivation of cardiac-specific human Isl1-ECs from human pluripotent stem cells, coupled with the ability to drive endothelial specification, engraftment, and survival following transplantation, suggest a novel strategy for vascular regeneration in the heart.
登录
查看更多内容
组蛋白脱乙酰基酶活性对于Hoxa9的表达和祖细胞的内皮承诺至关重要。
DOI：
10.1084/jem.20042097
发表时间：
2005-06-06
期刊：
The Journal of experimental medicine
影响因子：
--
作者：
Rössig L;Urbich C;Brühl T;Dernbach E;Heeschen C;Chavakis E;Sasaki K;Aicher D;Diehl F;Seeger F;Potente M;Aicher A;Zanetta L;Dejana E;Zeiher AM;Dimmeler S
通讯作者：
Dimmeler S
影响因子：
64.8
作者：
Laugwitz, KL;Moretti, A;Chien, KR
通讯作者：
Chien, KR
影响因子：
2.7
作者：
GARCIAMARTINEZ, V;SCHOENWOLF, GC
通讯作者：
SCHOENWOLF, GC
影响因子：
10.8
作者：
Diez, Marta;Musri, Melina M.;Peinado, Victor I.
通讯作者：
Peinado, Victor I.
影响因子：
23.9
作者：
Lee, Dongjun;Park, Changwon;Choi, Kyunghee
通讯作者：
Choi, Kyunghee